Back to funds

Propel Bio Management, LLC

hedge fundUpdated 9 days ago

Managed by Propel Bio Management, Llc • Latest filing Q3 2026

Portfolio value
$188.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$117.1M
Q1 2026$158.7M
Q2 2026$191.1M
Q3 2026$188.6M

Top holdings

30 positions as of Q3 2026

View filing
P

PLAINS GP HOLDINGS LP

Value
$33M
Shares
1.27M
% Port
17.47%
A

ACHIEVE LIFE SCIENCES INC

Value
$31.3M
Shares
3.86M
% Port
16.57%
D

DELCATH SYSTEMS INC

Value
$9.7M
Shares
604.7K
% Port
5.12%
C

COLLEGIUM PHARMACEUTICAL

Value
$9M
Shares
410.2K
% Port
4.75%
C

CORCEPT THERAPEUTICS INC

Value
$8.7M
Shares
75.3K
% Port
4.60%
A

AQUESTIVE THERAPEUTICS INC

Value
$8.6M
Shares
278.7K
% Port
4.56%
M

MILESTONE PHARMACEUTICALS

Value
$8.2M
Shares
9.45M
% Port
4.34%
P

PHATHOM PHARMACEUTICALS I

Value
$8.1M
Shares
1.11M
% Port
4.28%
C

COMPASS PATHWAYS PLC

Value
$6.8M
Shares
549.2K
% Port
3.62%
O

ORCHESTRA BIOMED HOLDINGS

Value
$5.6M
Shares
896.7K
% Port
2.96%
M

MAZE THERAPEUTICS INC

Value
$5.2M
Shares
192.0K
% Port
2.77%
A

ABEONA THERAPEUTICS INC

Value
$5M
Shares
956.0K
% Port
2.66%
A

ARTIVA BIOTHERAPEUTICS IN

Value
$5M
Shares
696.4K
% Port
2.63%
?
14.N/A

KYVERNA THERAPEUTICS INC

Value
$4.8M
Shares
700.6K
% Port
2.53%
I

INVENTIVA SA - ADR

Value
$4.2M
Shares
1.13M
% Port
2.22%
C

CABALETTA BIO INC

Value
$3.9M
Shares
2.05M
% Port
2.09%
S

SAB BIOTHERAPEUTICS INC

Value
$3.8M
Shares
1.19M
% Port
2.00%
P

PROKIDNEY CORP

Value
$3.3M
Shares
2.01M
% Port
1.77%
C

CORVUS PHARMACEUTICALS INC

Value
$3M
Shares
264.3K
% Port
1.61%
?
20.N/A

PALISADE BIO INC

Value
$3M
Shares
2.22M
% Port
1.59%

Explore